TD Cowen raised the firm’s price target on Emerson (EMR) to $150 from $130 and keeps a Buy rating on the shares following a transfer of coverage. The firm says strength in the company’s Process unit, a possible discrete recovery, and consistent upgrading of the margin profile through acquisitions drives its bullish view on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: